Decreased prevalence of lymphatic filariasis among diabetic subjects associated with a diminished pro-inflammatory cytokine response (CURES 83).
Identifieur interne : 002909 ( PubMed/Checkpoint ); précédent : 002908; suivant : 002910Decreased prevalence of lymphatic filariasis among diabetic subjects associated with a diminished pro-inflammatory cytokine response (CURES 83).
Auteurs : Vivekanandhan Aravindhan [Inde] ; Viswanathan Mohan ; Jayagopi Surendar ; Maradana Muralidhara Rao ; Nathella Pavankumar ; Mohan Deepa ; Ramanujam Rajagopalan ; Vasanthapuram Kumaraswami ; Thomas B. Nutman ; Subash BabuSource :
- PLoS neglected tropical diseases [ 1935-2735 ] ; 2010.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Anticorps antihelminthe (sang), Antigènes d'helminthe (sang), Cytokines (sang), Diabète de type 2 (parasitologie), Diabète de type 2 (sang), Diabète de type 2 (épidémiologie), Facteurs socioéconomiques, Femelle, Filariose lymphatique (), Filariose lymphatique (parasitologie), Filariose lymphatique (sang), Filariose lymphatique (épidémiologie), Humains, Immunomodulation, Inde (épidémiologie), Interactions hôte-parasite, Modèles logistiques, Mâle, Prévalence, Statistique non paramétrique, Études transversales.
- MESH :
- parasitologie : Diabète de type 2, Filariose lymphatique.
- sang : Anticorps antihelminthe, Antigènes d'helminthe, Cytokines, Diabète de type 2, Filariose lymphatique.
- épidémiologie : Diabète de type 2, Filariose lymphatique, Inde.
- Adulte, Adulte d'âge moyen, Facteurs socioéconomiques, Femelle, Filariose lymphatique, Humains, Immunomodulation, Interactions hôte-parasite, Modèles logistiques, Mâle, Prévalence, Statistique non paramétrique, Études transversales.
- Wicri :
- geographic : Inde.
English descriptors
- KwdEn :
- Adult, Antibodies, Helminth (blood), Antigens, Helminth (blood), Cross-Sectional Studies, Cytokines (blood), Diabetes Mellitus, Type 2 (blood), Diabetes Mellitus, Type 2 (epidemiology), Diabetes Mellitus, Type 2 (parasitology), Elephantiasis, Filarial (blood), Elephantiasis, Filarial (complications), Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (parasitology), Female, Host-Parasite Interactions, Humans, Immunomodulation, India (epidemiology), Logistic Models, Male, Middle Aged, Prevalence, Socioeconomic Factors, Statistics, Nonparametric.
- MESH :
- chemical , blood : Antibodies, Helminth, Antigens, Helminth, Cytokines.
- geographic , epidemiology : India.
- blood : Diabetes Mellitus, Type 2, Elephantiasis, Filarial.
- complications : Elephantiasis, Filarial.
- epidemiology : Diabetes Mellitus, Type 2, Elephantiasis, Filarial.
- parasitology : Diabetes Mellitus, Type 2, Elephantiasis, Filarial.
- Adult, Cross-Sectional Studies, Female, Host-Parasite Interactions, Humans, Immunomodulation, Logistic Models, Male, Middle Aged, Prevalence, Socioeconomic Factors, Statistics, Nonparametric.
Abstract
Epidemiological studies have shown an inverse correlation between the incidence of lymphatic filariasis (LF) and the incidence of allergies and autoimmunity. However, the interrelationship between LF and type-2 diabetes is not known and hence, a cross sectional study to assess the baseline prevalence and the correlates of sero-positivity of LF among diabetic subjects was carried out (n = 1416) as part of the CURES study. There was a significant decrease in the prevalence of LF among diabetic subjects (both newly diagnosed [5.7%] and those under treatment [4.3%]) compared to pre-diabetic subjects [9.1%] (p = 0.0095) and non-diabetic subjects [10.4%] (p = 0.0463). A significant decrease in filarial antigen load (p = 0.04) was also seen among diabetic subjects. Serum cytokine levels of the pro-inflammatory cytokines-IL-6 and GM-CSF-were significantly lower in diabetic subjects who were LF positive, compared to those who were LF negative. There were, however, no significant differences in the levels of anti-inflammatory cytokines-IL-10, IL-13 and TGF-beta-between the two groups. Although a direct causal link has yet to be shown, there appears to be a striking inverse relationship between the prevalence of LF and diabetes, which is reflected by a diminished pro-inflammatory cytokine response in Asian Indians with diabetes and concomitant LF.
DOI: 10.1371/journal.pntd.0000707
PubMed: 20559443
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:20559443Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Decreased prevalence of lymphatic filariasis among diabetic subjects associated with a diminished pro-inflammatory cytokine response (CURES 83).</title><author><name sortKey="Aravindhan, Vivekanandhan" sort="Aravindhan, Vivekanandhan" uniqKey="Aravindhan V" first="Vivekanandhan" last="Aravindhan">Vivekanandhan Aravindhan</name><affiliation wicri:level="1"><nlm:affiliation>Madras Diabetes Research Foundation, Chennai, India. cvaravindhan@yahoo.co.uk</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Madras Diabetes Research Foundation, Chennai</wicri:regionArea><wicri:noRegion>Chennai</wicri:noRegion></affiliation></author><author><name sortKey="Mohan, Viswanathan" sort="Mohan, Viswanathan" uniqKey="Mohan V" first="Viswanathan" last="Mohan">Viswanathan Mohan</name></author><author><name sortKey="Surendar, Jayagopi" sort="Surendar, Jayagopi" uniqKey="Surendar J" first="Jayagopi" last="Surendar">Jayagopi Surendar</name></author><author><name sortKey="Muralidhara Rao, Maradana" sort="Muralidhara Rao, Maradana" uniqKey="Muralidhara Rao M" first="Maradana" last="Muralidhara Rao">Maradana Muralidhara Rao</name></author><author><name sortKey="Pavankumar, Nathella" sort="Pavankumar, Nathella" uniqKey="Pavankumar N" first="Nathella" last="Pavankumar">Nathella Pavankumar</name></author><author><name sortKey="Deepa, Mohan" sort="Deepa, Mohan" uniqKey="Deepa M" first="Mohan" last="Deepa">Mohan Deepa</name></author><author><name sortKey="Rajagopalan, Ramanujam" sort="Rajagopalan, Ramanujam" uniqKey="Rajagopalan R" first="Ramanujam" last="Rajagopalan">Ramanujam Rajagopalan</name></author><author><name sortKey="Kumaraswami, Vasanthapuram" sort="Kumaraswami, Vasanthapuram" uniqKey="Kumaraswami V" first="Vasanthapuram" last="Kumaraswami">Vasanthapuram Kumaraswami</name></author><author><name sortKey="Nutman, Thomas B" sort="Nutman, Thomas B" uniqKey="Nutman T" first="Thomas B" last="Nutman">Thomas B. Nutman</name></author><author><name sortKey="Babu, Subash" sort="Babu, Subash" uniqKey="Babu S" first="Subash" last="Babu">Subash Babu</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2010">2010</date><idno type="RBID">pubmed:20559443</idno><idno type="pmid">20559443</idno><idno type="doi">10.1371/journal.pntd.0000707</idno><idno type="wicri:Area/PubMed/Corpus">002A20</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002A20</idno><idno type="wicri:Area/PubMed/Curation">002A20</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002A20</idno><idno type="wicri:Area/PubMed/Checkpoint">002A20</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002A20</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Decreased prevalence of lymphatic filariasis among diabetic subjects associated with a diminished pro-inflammatory cytokine response (CURES 83).</title><author><name sortKey="Aravindhan, Vivekanandhan" sort="Aravindhan, Vivekanandhan" uniqKey="Aravindhan V" first="Vivekanandhan" last="Aravindhan">Vivekanandhan Aravindhan</name><affiliation wicri:level="1"><nlm:affiliation>Madras Diabetes Research Foundation, Chennai, India. cvaravindhan@yahoo.co.uk</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Madras Diabetes Research Foundation, Chennai</wicri:regionArea><wicri:noRegion>Chennai</wicri:noRegion></affiliation></author><author><name sortKey="Mohan, Viswanathan" sort="Mohan, Viswanathan" uniqKey="Mohan V" first="Viswanathan" last="Mohan">Viswanathan Mohan</name></author><author><name sortKey="Surendar, Jayagopi" sort="Surendar, Jayagopi" uniqKey="Surendar J" first="Jayagopi" last="Surendar">Jayagopi Surendar</name></author><author><name sortKey="Muralidhara Rao, Maradana" sort="Muralidhara Rao, Maradana" uniqKey="Muralidhara Rao M" first="Maradana" last="Muralidhara Rao">Maradana Muralidhara Rao</name></author><author><name sortKey="Pavankumar, Nathella" sort="Pavankumar, Nathella" uniqKey="Pavankumar N" first="Nathella" last="Pavankumar">Nathella Pavankumar</name></author><author><name sortKey="Deepa, Mohan" sort="Deepa, Mohan" uniqKey="Deepa M" first="Mohan" last="Deepa">Mohan Deepa</name></author><author><name sortKey="Rajagopalan, Ramanujam" sort="Rajagopalan, Ramanujam" uniqKey="Rajagopalan R" first="Ramanujam" last="Rajagopalan">Ramanujam Rajagopalan</name></author><author><name sortKey="Kumaraswami, Vasanthapuram" sort="Kumaraswami, Vasanthapuram" uniqKey="Kumaraswami V" first="Vasanthapuram" last="Kumaraswami">Vasanthapuram Kumaraswami</name></author><author><name sortKey="Nutman, Thomas B" sort="Nutman, Thomas B" uniqKey="Nutman T" first="Thomas B" last="Nutman">Thomas B. Nutman</name></author><author><name sortKey="Babu, Subash" sort="Babu, Subash" uniqKey="Babu S" first="Subash" last="Babu">Subash Babu</name></author></analytic><series><title level="j">PLoS neglected tropical diseases</title><idno type="eISSN">1935-2735</idno><imprint><date when="2010" type="published">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Antibodies, Helminth (blood)</term><term>Antigens, Helminth (blood)</term><term>Cross-Sectional Studies</term><term>Cytokines (blood)</term><term>Diabetes Mellitus, Type 2 (blood)</term><term>Diabetes Mellitus, Type 2 (epidemiology)</term><term>Diabetes Mellitus, Type 2 (parasitology)</term><term>Elephantiasis, Filarial (blood)</term><term>Elephantiasis, Filarial (complications)</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Elephantiasis, Filarial (parasitology)</term><term>Female</term><term>Host-Parasite Interactions</term><term>Humans</term><term>Immunomodulation</term><term>India (epidemiology)</term><term>Logistic Models</term><term>Male</term><term>Middle Aged</term><term>Prevalence</term><term>Socioeconomic Factors</term><term>Statistics, Nonparametric</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Anticorps antihelminthe (sang)</term><term>Antigènes d'helminthe (sang)</term><term>Cytokines (sang)</term><term>Diabète de type 2 (parasitologie)</term><term>Diabète de type 2 (sang)</term><term>Diabète de type 2 (épidémiologie)</term><term>Facteurs socioéconomiques</term><term>Femelle</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (parasitologie)</term><term>Filariose lymphatique (sang)</term><term>Filariose lymphatique (épidémiologie)</term><term>Humains</term><term>Immunomodulation</term><term>Inde (épidémiologie)</term><term>Interactions hôte-parasite</term><term>Modèles logistiques</term><term>Mâle</term><term>Prévalence</term><term>Statistique non paramétrique</term><term>Études transversales</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Helminth</term><term>Antigens, Helminth</term><term>Cytokines</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>India</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Diabetes Mellitus, Type 2</term><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Diabetes Mellitus, Type 2</term><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="parasitologie" xml:lang="fr"><term>Diabète de type 2</term><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="parasitology" xml:lang="en"><term>Diabetes Mellitus, Type 2</term><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antihelminthe</term><term>Antigènes d'helminthe</term><term>Cytokines</term><term>Diabète de type 2</term><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Diabète de type 2</term><term>Filariose lymphatique</term><term>Inde</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Cross-Sectional Studies</term><term>Female</term><term>Host-Parasite Interactions</term><term>Humans</term><term>Immunomodulation</term><term>Logistic Models</term><term>Male</term><term>Middle Aged</term><term>Prevalence</term><term>Socioeconomic Factors</term><term>Statistics, Nonparametric</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Facteurs socioéconomiques</term><term>Femelle</term><term>Filariose lymphatique</term><term>Humains</term><term>Immunomodulation</term><term>Interactions hôte-parasite</term><term>Modèles logistiques</term><term>Mâle</term><term>Prévalence</term><term>Statistique non paramétrique</term><term>Études transversales</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Inde</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Epidemiological studies have shown an inverse correlation between the incidence of lymphatic filariasis (LF) and the incidence of allergies and autoimmunity. However, the interrelationship between LF and type-2 diabetes is not known and hence, a cross sectional study to assess the baseline prevalence and the correlates of sero-positivity of LF among diabetic subjects was carried out (n = 1416) as part of the CURES study. There was a significant decrease in the prevalence of LF among diabetic subjects (both newly diagnosed [5.7%] and those under treatment [4.3%]) compared to pre-diabetic subjects [9.1%] (p = 0.0095) and non-diabetic subjects [10.4%] (p = 0.0463). A significant decrease in filarial antigen load (p = 0.04) was also seen among diabetic subjects. Serum cytokine levels of the pro-inflammatory cytokines-IL-6 and GM-CSF-were significantly lower in diabetic subjects who were LF positive, compared to those who were LF negative. There were, however, no significant differences in the levels of anti-inflammatory cytokines-IL-10, IL-13 and TGF-beta-between the two groups. Although a direct causal link has yet to be shown, there appears to be a striking inverse relationship between the prevalence of LF and diabetes, which is reflected by a diminished pro-inflammatory cytokine response in Asian Indians with diabetes and concomitant LF.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20559443</PMID><DateCreated><Year>2010</Year><Month>06</Month><Day>18</Day></DateCreated><DateCompleted><Year>2010</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1935-2735</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>6</Issue><PubDate><Year>2010</Year><Month>Jun</Month><Day>15</Day></PubDate></JournalIssue><Title>PLoS neglected tropical diseases</Title><ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation></Journal><ArticleTitle>Decreased prevalence of lymphatic filariasis among diabetic subjects associated with a diminished pro-inflammatory cytokine response (CURES 83).</ArticleTitle><Pagination><MedlinePgn>e707</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0000707</ELocationID><Abstract><AbstractText>Epidemiological studies have shown an inverse correlation between the incidence of lymphatic filariasis (LF) and the incidence of allergies and autoimmunity. However, the interrelationship between LF and type-2 diabetes is not known and hence, a cross sectional study to assess the baseline prevalence and the correlates of sero-positivity of LF among diabetic subjects was carried out (n = 1416) as part of the CURES study. There was a significant decrease in the prevalence of LF among diabetic subjects (both newly diagnosed [5.7%] and those under treatment [4.3%]) compared to pre-diabetic subjects [9.1%] (p = 0.0095) and non-diabetic subjects [10.4%] (p = 0.0463). A significant decrease in filarial antigen load (p = 0.04) was also seen among diabetic subjects. Serum cytokine levels of the pro-inflammatory cytokines-IL-6 and GM-CSF-were significantly lower in diabetic subjects who were LF positive, compared to those who were LF negative. There were, however, no significant differences in the levels of anti-inflammatory cytokines-IL-10, IL-13 and TGF-beta-between the two groups. Although a direct causal link has yet to be shown, there appears to be a striking inverse relationship between the prevalence of LF and diabetes, which is reflected by a diminished pro-inflammatory cytokine response in Asian Indians with diabetes and concomitant LF.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aravindhan</LastName><ForeName>Vivekanandhan</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Madras Diabetes Research Foundation, Chennai, India. cvaravindhan@yahoo.co.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohan</LastName><ForeName>Viswanathan</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Surendar</LastName><ForeName>Jayagopi</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Muralidhara Rao</LastName><ForeName>Maradana</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Pavankumar</LastName><ForeName>Nathella</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Deepa</LastName><ForeName>Mohan</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Rajagopalan</LastName><ForeName>Ramanujam</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Kumaraswami</LastName><ForeName>Vasanthapuram</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Nutman</LastName><ForeName>Thomas B</ForeName><Initials>TB</Initials></Author><Author ValidYN="Y"><LastName>Babu</LastName><ForeName>Subash</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Negl Trop Dis</MedlineTA><NlmUniqueID>101291488</NlmUniqueID><ISSNLinking>1935-2727</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000909">Antibodies, Helminth</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000947">Antigens, Helminth</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2008 Oct;79(4):558-60</RefSource><PMID Version="1">18840744</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2009 May 27;301(20):2129-40</RefSource><PMID Version="1">19470990</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Endocrinol. 2009 Jun;5(6):305-11</RefSource><PMID Version="1">19399017</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2005 Aug 1;41(3):281-8</RefSource><PMID Version="1">16007521</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2008 Jul 15;5(7):e152</RefSource><PMID Version="1">18630984</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pak J Biol Sci. 2009 May 1;12(9):746-9</RefSource><PMID Version="1">19634484</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Gastroenterol. 2008 Jul-Sep;29(3):121-2</RefSource><PMID Version="1">19115602</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2003 Jul;170(1):337</RefSource><PMID Version="1">14567342</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Assoc Physicians India. 2003 Sep;51:863-70</RefSource><PMID Version="1">14710970</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 1995 Sep 23;346(8978):853-4</RefSource><PMID Version="1">7674790</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2006 Mar 1;176(5):3248-56</RefSource><PMID Version="1">16493086</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 1988 Nov;158(5):1034-7</RefSource><PMID Version="1">2460565</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 1999 Jun;67(6):3166-7</RefSource><PMID Version="1">10338538</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes Res Clin Pract. 1995 May;28(2):137-46</RefSource><PMID Version="1">7587921</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2006 May;74(5):841-7</RefSource><PMID Version="1">16687690</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Trop Pediatr. 1993 Aug;39(4):257-60</RefSource><PMID Version="1">8411323</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Immunol. 2009 Jan;39(1):192-206</RefSource><PMID Version="1">19089814</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Commun Dis. 2007 Sep;39(3):197-9</RefSource><PMID Version="1">18697586</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Med Assoc. 2006 Nov;98(11):1805-8</RefSource><PMID Version="1">17128691</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Interferon Cytokine Res. 2004 Jul;24(7):381-7</RefSource><PMID Version="1">15296648</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Assoc Physicians India. 2008 Mar;56:149-51</RefSource><PMID Version="1">18697629</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Exp Immunol. 2008 Jan;151(1):42-50</RefSource><PMID Version="1">18005364</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunology. 2009 Aug;127(4):512-22</RefSource><PMID Version="1">19016910</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Sci Monit. 2005 Dec;11(12):CR580-4</RefSource><PMID Version="1">16319789</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2005 Jun;73(6):3394-401</RefSource><PMID Version="1">15908366</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetologia. 2006 Jun;49(6):1175-8</RefSource><PMID Version="1">16570158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Natl Med J India. 2003 Mar-Apr;16(2):73-8</RefSource><PMID Version="1">12816185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Assoc Physicians India. 2009 May;57:407-9</RefSource><PMID Version="1">19634290</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbes Infect. 2006 Aug;8(9-10):2414-23</RefSource><PMID Version="1">16839794</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2009 Jul 15;183(2):916-24</RefSource><PMID Version="1">19561105</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000909" MajorTopicYN="N">Antibodies, Helminth</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000947" MajorTopicYN="N">Antigens, Helminth</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006790" MajorTopicYN="N">Host-Parasite Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056747" MajorTopicYN="N">Immunomodulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018709" MajorTopicYN="N">Statistics, Nonparametric</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC2886036</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>04</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20559443</ArticleId><ArticleId IdType="doi">10.1371/journal.pntd.0000707</ArticleId><ArticleId IdType="pmc">PMC2886036</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Inde</li></country></list><tree><noCountry><name sortKey="Babu, Subash" sort="Babu, Subash" uniqKey="Babu S" first="Subash" last="Babu">Subash Babu</name><name sortKey="Deepa, Mohan" sort="Deepa, Mohan" uniqKey="Deepa M" first="Mohan" last="Deepa">Mohan Deepa</name><name sortKey="Kumaraswami, Vasanthapuram" sort="Kumaraswami, Vasanthapuram" uniqKey="Kumaraswami V" first="Vasanthapuram" last="Kumaraswami">Vasanthapuram Kumaraswami</name><name sortKey="Mohan, Viswanathan" sort="Mohan, Viswanathan" uniqKey="Mohan V" first="Viswanathan" last="Mohan">Viswanathan Mohan</name><name sortKey="Muralidhara Rao, Maradana" sort="Muralidhara Rao, Maradana" uniqKey="Muralidhara Rao M" first="Maradana" last="Muralidhara Rao">Maradana Muralidhara Rao</name><name sortKey="Nutman, Thomas B" sort="Nutman, Thomas B" uniqKey="Nutman T" first="Thomas B" last="Nutman">Thomas B. Nutman</name><name sortKey="Pavankumar, Nathella" sort="Pavankumar, Nathella" uniqKey="Pavankumar N" first="Nathella" last="Pavankumar">Nathella Pavankumar</name><name sortKey="Rajagopalan, Ramanujam" sort="Rajagopalan, Ramanujam" uniqKey="Rajagopalan R" first="Ramanujam" last="Rajagopalan">Ramanujam Rajagopalan</name><name sortKey="Surendar, Jayagopi" sort="Surendar, Jayagopi" uniqKey="Surendar J" first="Jayagopi" last="Surendar">Jayagopi Surendar</name></noCountry><country name="Inde"><noRegion><name sortKey="Aravindhan, Vivekanandhan" sort="Aravindhan, Vivekanandhan" uniqKey="Aravindhan V" first="Vivekanandhan" last="Aravindhan">Vivekanandhan Aravindhan</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002909 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002909 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:20559443
|texte= Decreased prevalence of lymphatic filariasis among diabetic subjects associated with a diminished pro-inflammatory cytokine response (CURES 83).
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:20559443" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |